Alterity Therapeutics Operating Income

Alterity Therapeutics (ATHE) currently reports a operating income of $-27M as of December 2025. That compares with $-22M in the prior-year period — down 25.3% year over year. Use the charts on this page to explore Alterity Therapeutics's operating income history and peer comparisons.

Alterity Therapeutics's operating income decreased from $-22M to $-27M — a 25.3% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alterity Therapeutics reported $-27M in operating income as of December 2025. That compares with $-22M in the prior-year period — down 25.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-27M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alterity Therapeutics, and consider following ATHE for alerts when major investors trade the stock.

Alterity Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $-27M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATHE with unrelated industries.